3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

[1]  Joshua C. Johnson,et al.  Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease , 2015, Virology.

[2]  Ulas Bagci,et al.  Evaluation of candidate vaccine approaches for MERS-CoV , 2015, Nature Communications.

[3]  Xiaoyan Lu,et al.  MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013–2014 , 2015, Emerging infectious diseases.

[4]  G. Yancopoulos,et al.  Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection , 2015, Proceedings of the National Academy of Sciences.

[5]  Mohammed F. Yusof,et al.  Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates , 2015, Virus Genes.

[6]  R. Couch,et al.  Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease , 2015, Journal of Virology.

[7]  F. Berthe,et al.  Human–Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection , 2014, Zoonoses and public health.

[8]  V. Brown,et al.  Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels , 2014, Emerging infectious diseases.

[9]  D. Dimitrov,et al.  Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections , 2014, Microbes and Infection.

[10]  Xinxia Peng,et al.  Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset , 2014, PLoS pathogens.

[11]  Jincun Zhao,et al.  Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection , 2014, Journal of Virology.

[12]  Jayaram K. Udupa,et al.  A Generic Approach to Pathological Lung Segmentation , 2014, IEEE Transactions on Medical Imaging.

[13]  Jincun Zhao,et al.  T cell-mediated immune response to respiratory coronaviruses , 2014, Immunologic Research.

[14]  K. Yuen,et al.  Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein , 2014, Science Translational Medicine.

[15]  R. Baric,et al.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution , 2014, Proceedings of the National Academy of Sciences.

[16]  R. Baric,et al.  Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.

[17]  X. Qiu,et al.  Antibody therapy for Ebola , 2014, Human vaccines & immunotherapeutics.

[18]  Honglin Chen,et al.  An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus , 2013, The Journal of infectious diseases.

[19]  Michael G. Katze,et al.  Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques , 2013, Proceedings of the National Academy of Sciences.

[20]  Ulas Bagci,et al.  Spatially Constrained Random Walk Approach for Accurate Estimation of Airway Wall Surfaces , 2013, MICCAI.

[21]  Christian Drosten,et al.  Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.

[22]  H. Feldmann,et al.  Pneumonia from human coronavirus in a macaque model. , 2013, The New England journal of medicine.

[23]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[24]  O. Bohorov,et al.  Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model , 2013, mAbs.

[25]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[26]  R. Pebody,et al.  The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[27]  T. Bestebroer,et al.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  E. Wald,et al.  A review of palivizumab and emerging therapies for respiratory syncytial virus , 2011, Expert opinion on biological therapy.

[29]  C. Broder,et al.  A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection , 2009, PLoS pathogens.

[30]  G. Stiegler,et al.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.

[31]  W. Marasco,et al.  The growth and potential of human antiviral monoclonal antibody therapeutics , 2007, Nature Biotechnology.

[32]  Carola Engler,et al.  Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.

[33]  Paul W. H. I. Parren,et al.  Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 , 2001, Journal of Virology.

[34]  G. Shopp,et al.  Bronchoalveolar Lavage Cytology in Cynomolgus Monkeys and Identification of Cytologic Alterations Following Sequential Saline Lavage , 1989, Veterinary pathology.

[35]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[36]  S. V. Von Essen,et al.  Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. , 1991, The American review of respiratory disease.

[37]  V. Georgiev Virology , 1955, Nature.